OP0152 Effects of Tofacitinib Monotherapy versus Methotrexate on Patient-Reported Outcomes in the 2-Year Phase 3 Oral Start TRIAL in Methotrexate-NaÏVe Patients with Rheumatoid Arthritis
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 118.2-119
◽
Keyword(s):
Phase 3
◽